Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Serum testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH) and prolactin (PRL) responses to exposure to sea-level altitude (LA) were examined in 13 eugonadal males, age 21-22 yr, 3 and 5 days after residing at LA and on the second day of return to basal altitude 90 days later. After 3 days at their respective residence altitude, there was elevation in LH (p less than 0.05) and depression in testosterone levels (p less than 0.05), with similar results on day 5. These effects were all of transient nature, LH and testosterone concentrations returned to their basal levels on second day of the return to basal altitude. The FSH and PRL levels did not show any significant change during the stay at LA or after return to basal altitude. The observations suggest that exposure to LA is associated with increase in plasma levels of LH and decrease in testosterone. The decreased levels of testosterone could be due to a reduction in the sensitivity of the testis to LH, or due to inhibition of steroidogenesis in the testis.
 ...
PMID:Effect of exposure to the altitude of 300 meters below sea-level on testosterone, luteinizing hormone, follicle-stimulating hormone and prolactin in man. 314 60

The authors made a randomized prospective study of estrogen therapy versus orchidectomy in patients with prostatic cancer (n = 100, Huddinge Hospital, Sweden) to investigate the possibility of predicting cardiovascular events during hormonal treatment. Patients with preexisting cardiovascular morbidity were excluded (16%). Prior to the allocation of therapy, the following were performed: exercise stress test; physiologic evaluation of the peripheral circulation; blood volume estimation; chest x-ray; blood tests, including hormones, lipoproteins, and antithrombin III; and a physical examination and history by a cardiologist. Thirteen (25%) of the patients given estrogen therapy (n = 53) had cardiovascular complications during the first year of treatment compared with none in the orchidectomy group. The authors made a multivariate discriminant analysis of the pretreatment examinations of the estrogen-treated patients; this resulted in a discriminant function including S-T segment depression in lead CH2 during the exercise stress test and blood tests for cholesterol, follicle-stimulating hormone, and luteinizing hormone. This function correctly classified 84% of the estrogen-treated patients as patients with or without risk of a cardiovascular complication. Briefly stated, if patients with prostatic cancer are examined by means of exercise stress tests and blood tests for luteinizing hormone, cholesterol, and follicle-stimulating hormone prior to treatment, the discriminant function enables the authors to identify an extremely high-risk group for cardiovascular complications if estrogen therapy is commenced. The strong association of an increased luteinizing hormone with cardiovascular complications during estrogen treatment makes it mandatory to investigate its role in the pathogenesis of atherosclerosis and cardiovascular events.
 ...
PMID:Prediction of cardiovascular complications in patients with prostatic cancer treated with estrogen. 357 55

Long-Evans rat pups were dosed orally from birth to 21 d with particulate Mn3O4 to obtain a daily dose of 0, 71, or 214 micrograms Mn/body weight . d. Assessments of the hypothalamic, pituitary, or testicular functions were determined by measuring the endogenous or stimulated serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and/or testosterone (T) at 21 or 28 d of age. Body, testes, and seminal vesicles weight and tissue concentrations of Mn were also evaluated. Only slight Mn treatment effects were seen in body and testes weights. No effects were seen either on unstimulated or stimulated FSH or LH serum concentrations. Although no Mn treatment effects were seen on endogenous or 2 h human chorionic gonadotropin (hCG) stimulate serum T concentrations, there was a reduction in the serum T following 7 d of hCG stimulation. The hypothalamic Mn concentrations in animals with these reproductive effects were three times those where alterations in the dopaminergic pathway have been reported. However, no indication of hypothalamic or pituitary malfunction was found. These results suggest that the site of Mn damage that causes depression of sustained serum T concentration is in the testicular Leydig cell.
 ...
PMID:Assessment of the male reproductive system in the preweanling rat following Mn3O4 exposure. 392 53

Treatment of male rat pups from five to 34 days of age with dihydrotestosterone or 5 alpha-androstane-3 alpha, 17 beta-diol, resulted in reduced testicular size at 35 days of age. This appeared to be due to decreased tubular diameters and reduced spermatocyte numbers, especially late pachytene cells in stages X to XIII. In rat pups treated with dihydrotestosterone or 5 alpha-androstane-3 alpha, 17 beta-diol, treatment with luteinizing hormone resulted in some restoration of tubular diameter and spermatocyte numbers. In 5 alpha-androstane-3 alpha, 17 beta-diol treated rat pups partial restoration of testes size resulted from follicle-stimulating hormone treatment, but tubular diameter and spermatocyte numbers were depressed. Single serum samples collected at 35 days of age were analysed for luteinizing and follicle-stimulating hormone concentrations. These data indicated that the effects of administered androgens were due primarily to depression of circulating gonadotropin concentrations but a direct inhibition at the level of the testis could not be ruled out.
 ...
PMID:The effects of androgens and gonadotropins on testicular development in the prepubertal rat. 393 58

Incorporation of 3H-uridine by RNA in Tetrahymena was differently influenced by insulin, glucagon, follicle-stimulating hormone (FSH), thyrotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and chorion-gonadotropic hormone (PMSG). TSH caused it to increase considerably and durably after an initial depression, while glucagon caused it to rise over the control throughout. Insulin, and especially PMSG, depressed the incorporation of label considerably, the latter to 3-6% of the control value by 120 min. ACTH and FSH accounted for an initial depression of RNA synthesis which, however, returned to normal 30 min after treatment. Remarkably, while the chemically similar hormones acted differently, insulin and glucagon showed the same trend of positive and negative influence, respectively.
 ...
PMID:Effect of polypeptide hormones (insulin, thyrotropin, gonadotropin, adrenocorticotropin) on RNA synthesis in Tetrahymena, as assessed from incorporation of 3H-uridine. 618 2

To inhibit endometrial stimulation during postmenopausal estrogen therapy, 25 women with climacteric symptoms were treated with a daily dose of 1.25 mg of conjugated estrogens for 7 weeks followed by a period of 10 days with clomiphene citrate administration (50 mg per day). This combination was repeated three times during the 6-month trial. The marked relief of climacteric symptoms with estrogen was slightly less during clomiphene treatment. Uterine bleeding occurred five times during estrogen treatment periods but never during or after clomiphene supplementation. Histologic examination revealed endometrial atrophy in 41% of the samples after the first estrogen treatment, whereas after the first and third clomiphene periods this was increased to 77% and 73%, respectively. The first clomiphene treatment significantly decreased the concentrations of cytosol estrogen and progestin receptors in endometrium, as compared with the levels recorded at the end of the preceding estrogen therapy. The depression in the cytosol estrogen receptor concentration was persistent, whereas cytosol progestin receptor concentration tended to increase during the subsequent estrogen-plus-clomiphene treatment. Estrogen declined serum concentration of follicle-stimulating hormone (FSH), whereas the concentration of luteinizing hormone (LH) and prolactin remained unchanged. Clomiphene did not change the levels of these hormones from those observed during the estrogen treatment. The concentration of free fatty acids in serum was increased during the estrogen and clomiphene treatments, whereas the levels of cholesterol and high-density lipoprotein--cholesterol did not change. Our results suggest that this treatment regimen relieves climacteric symptoms without endometrial stimulation or other adverse effects. Thus, clomiphene appears to be a practical alternative to progestin for interruption of the postmenopausal endometrial effect of estrogen.
 ...
PMID:Postmenopausal hormone replacement therapy with estrogen periodically supplemented with antiestrogen. 626 54

Luteinizing hormone, testosterone, and follicle-stimulating hormone were evaluated by radioimmunoassay in two patients with Briquet's disorder, secondary depression, and menstrual irregularity. In both patients a hormonal pattern consistent with polycystic ovary disease was documented. The ovaries of both patients showed the classic pathologic findings of this disease. These results suggest that the hormonal and ovarian pathologic abnormalities of polycystic ovary disease may be common in patients with menstrual irregularity and Briquet's disorder.
 ...
PMID:Polycystic ovary disease in two patients with Briquet's disorder. 641 73

The current experiment was conducted with beef cows during the first 2 weeks postpartum (PP) to determine the effects of suckling and low-level increases of systemic progesterone on secretory characteristics of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in peripheral plasma. Variables measured included mean gonadotropin concentrations, FSH/LH pulse frequencies, pulse amplitudes and synchrony of coincident release. Suckled (S) cows had lower (P less than 0.01-P less than 0.05) mean concentrations of FSH and LH in plasma, lower (P less than .05) FSH and LH pulse frequencies and a lower (P less than 0.05) pulse synchrony (21.6 vs 72.3% coincident pulses) than nonsuckled (NS) cows on Day 7 PP. Neither FSH nor LH pulse amplitude was affected by suckling. Similar differences existed for mean gonadotropin concentrations, pulse frequencies and pulse synchrony on Day 14 PP between S and NS cows. Implanting cows with progesterone implants on Day 7 PP, which chronically increased plasma progesterone to 0.5-0.6 ng/ml, increased (P less than 0.05) mean plasma FSH and LH concentrations, FSH and LH pulse frequencies and pulse synchrony (87.5 vs. 66.3%) in NS-implanted (NSI) versus NS-nonimplanted (NSNI) cows. Progesterone implants had no beneficial effect in S cows. Thus, three major findings seem pertinent: 1) associated with the suckling-induced depression of episodic gonadotropin release was a marked decline in FSH/LH pulse synchrony; 2) a high degree of FSH/LH pulse synchrony (72-88%) was restored in the absence of suckling when gonadotropin pulse frequency increased to 4-5/6 h; 3) the absence of suckling, followed by the provision of low-level progesterone stimulation for 7 days, appeared to have additive effects on FSH and LH secretion. These results provide evidence that the neuroendocrine block associated with suckling in early PP beef cows is, in addition to being associated with depressed LH release, comprised of characteristic anomalies in FSH secretion, FSH/LH pulse synchrony and failure to respond to a putative hypothalamo-hypophyseal potentiator, progesterone.
 ...
PMID:Coincident secretion of follicle-stimulating hormone and luteinizing hormone in early postpartum beef cows: effects of suckling and low-level increases of systemic progesterone. 641 11

The effects of (D-Met2,Pro5)-enkephalinamide--a superactive enkephalin analogue--on the preovulatory discharge of gonadotrophic hormones and on ovulation were investigated. Injection of the opioid (16 nmol) into a lateral cerebral ventricle of regularly cycling female rats immediately before the critical period on the day of proestrus resulted in a blockade of ovulation and in a concomitant depression of the preovulatory plasma luteinizing hormone and follicle-stimulating hormone levels. A smaller dose of the opioid (2 nmol) did not inhibit ovulation. The inhibition of the preovulatory gonadotrophic hormone discharge and the blockade of ovulation by the opioid were reversed by naloxone administration. Our data are consistent with the view that the endogenous opioid peptides may be involved in the physiological regulation of the central neural events which lead to ovulation in the rat.
 ...
PMID:(D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat. 678

This study was undertaken to investigate the intricate relations between prelaying nest-building activity and preovulatory hormonal changes, and the effects of these events on breeding success. Pairs of ring doves were allowed to go through a complete breeding cycle under four conditions of nest-building opportunity. Nest were self-made, pre-made, pre-made and covered, or removed daily to generate various levels of building activity. Behavioral and hormonal changes were observed throughout the cycle. Blood levels of gonadotrophins were monitored by daily measurements with the method or radioimmunoassay. A depression of follicle-stimulating hormone (FSH) typically was associated with every preovulatory surge of luteinizing hormone (LH); an LH surge not accompanied by a FSH dip was not followed by ovulation. Moreover, the FSH depression was significantly correlated with the level of nest-building activity. These findings led to the proposal that nest-building activity stimulated preovulatory FSH change and, hence, ovulation. The constructed nest in turn appeared to promote incubation behavior. These results are discussed in the context of breeding success.
 ...
PMID:The role of nest-building activity of gonadotrophin secretions and the reproductive success of ring doves (Streptopelia risoria). 680 86


<< Previous 1 2 3 4 5 6 Next >>